La crescita del mercato dei test rapidi veterinari è attribuita alla crescente incidenza delle malattie zoonotiche e alle crescenti iniziative da parte dei governi e delle associazioni per il benessere degli animali in diversi paesi . Tuttavia, il numero limitato di professionisti qualificati nella diagnostica veterinaria e l’aumento dei costi delle cure veterinarie stanno frenando la crescita del mercato. I test rapidi veterinari forniscono un risultato positivo o negativo per facilitare la diagnosi di una varietà di disturbi di salute negli animali da compagnia e negli animali da allevamento. Questi test aiutano a monitorare e controllare le malattie zoonotiche (malattie infettive trasmesse da altri animali o dall'uomo). Il test viene effettuato posizionando un campione sul pozzetto portacampione presente sul dispositivo. I risultati si ottengono una volta completata l'interazione antigene-anticorpo, risultando in un indicatore visibile sul dispositivo. Questi kit di test rapidi possono fornire un rilevamento efficace degli agenti patogeni in un breve periodo di tempo; circa 5-10 minuti.
Nell'Asia del Pacifico, le adozioni di animali domestici sono aumentate durante questa situazione pandemica. Ad esempio, un sondaggio del 2020 condotto dalla Japan Pet Food Association ha rilevato un aumento del 15% nel possesso di cani e gatti rispetto all’anno precedente (2019). Si stima che a ottobre 2020 in Giappone fossero tenuti come animali domestici 8,49 milioni di cani e 9,64 milioni di gatti. Diversi rifugi per animali, organizzazioni di soccorso senza scopo di lucro, allevatori privati e negozi di animali hanno osservato un aumento della domanda dei consumatori. Pertanto, la crescente adozione di animali domestici potrebbe guidare le attività sanitarie veterinarie nell'Asia del Pacifico a lungo termine.Regioni redditizie per il mercato dei test rapidi veterinari
Approfondimenti di mercato La crescente incidenza delle malattie zoonotiche alimenta la crescita del mercato dei test rapidi veterinariÈ probabile che un aumento delle malattie zoonotiche guidi il mercato dei test rapidi veterinari. A volte gli animali possono trasportare germi nocivi che possono diffondersi alle persone e causare malattie; queste sono conosciute come malattie zoonotiche o zoonosi. Le malattie zoonotiche sono causate da germi nocivi come batteri, virus, parassiti e funghi. Questi germi possono causare molti tipi diversi di malattie nelle persone e negli animali, da malattie lievi a gravi e persino alla morte. Le malattie zoonotiche sono prevalenti, sia negli Stati Uniti che nel mondo. Secondo il CDC, più di sei malattie infettive su dieci conosciute nell’uomo possono essere trasmesse dagli animali e tre su quattro malattie infettive nuove o imminenti nell’uomo provengono da animali. Inoltre, nel 2016 sono state dichiarate morte a causa della rabbia almeno 55.000 persone in Asia e in Africa.
Epidemie come la sindrome respiratoria acuta grave (SARS) e l'influenza aviaria si sono manifestate ancora una volta il potenziale dei microrganismi provenienti dai serbatoi animali di adattarsi agli ospiti umani. Negli ultimi decenni, molte malattie infettive umane precedentemente sconosciute sono emerse da serbatoi animali, da agenti come il virus Ebola, il virus dell’immunodeficienza umana (HIV), il virus Nipah, il virus del Nilo occidentale e l’Hantavirus. Più di tre quarti delle malattie umane nuove, emergenti o riemergenti all’inizio del 21° secolo sono causate da agenti patogeni originati da animali o prodotti di origine animale. Secondo l'OMS, circa il 60% delle malattie infettive emergenti segnalate a livello globale sono zoonosi e ogni anno a causa delle zoonosi si verificano circa un miliardo di casi di malattia e milioni di decessi. Approfondimenti basati sul prodottoIn base al prodotto, il mercato dei test rapidi veterinari è ulteriormente segmentato in kit di test rapidi e lettori di test rapidi. Il segmento dei kit per test rapidi detiene la quota maggiore del mercato e si prevede che lo stesso segmento registrerà il CAGR più elevato nel periodo 2021-2028. I kit di test rapidi offrono la flessibilità di eseguire test singoli o multipli in modo che il test venga eseguito secondo necessità per prendere le giuste decisioni cliniche ed evitare sprechi di tempo e denaro.Mercato dei test rapidi veterinari, per prodotto - 2021 e 2028
Approfondimenti basati sull'applicazioneIn base all'applicazione, il mercato dei test rapidi veterinari è ulteriormente segmentato in malattie virali, malattie batteriche, malattie parassitarie, allergie e altre applicazioni. Il segmento delle malattie virali detiene la quota maggiore del mercato dei test rapidi veterinari e si prevede che registrerà il CAGR più elevato sul mercato durante il periodo di previsione. Il rilevamento rapido di agenti infettivi sia negli animali che nell'ambiente è essenziale per un controllo efficace delle malattie infettive. Approfondimenti basati sul tipo di animaleBasati In base al tipo di animale, il mercato dei test rapidi veterinari è segmentato in animali da compagnia e animali da allevamento. Il segmento degli animali da compagnia è suddiviso in cani, gatti, cavalli e altri. Il segmento degli animali da allevamento è ulteriormente suddiviso in bovini, pollame, suini e altri. Il segmento degli animali da allevamento detiene la quota maggiore del mercato dei test rapidi veterinari. Tuttavia, si prevede che il segmento degli animali da compagnia registrerà il CAGR più elevato sul mercato durante il periodo di previsione. La crescente domanda di carne e l'aumento dell'incidenza di malattie infettive stanno guidando il segmento. Approfondimenti strategici< /div>Le aziende che operano nel mercato dei test rapidi veterinari stanno adottando la strategia di innovazione dei prodotti per soddisfare le richieste in continua evoluzione dei clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio nel mercato globale.
Mercato dei test rapidi veterinari - per prodotto
- Kit di test rapidi
- Lettori di test rapidi
Mercato dei test rapidi veterinari - per applicazione
- Malattie virali
- Malattie batteriche
- Malattie parassitarie
- Allergie
- Altre applicazioni
Mercato dei test rapidi veterinari - per tipo di animale
- Animali da allevamento
- Bovini
- Pollame
- Suini
- Altro
- Animali da compagnia
- Cani
- Gatti
- Cavalli
- Altro
Mercato dei test rapidi veterinari - per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania
- Italia
- Regno Unito
- Spagna < li>Resto d'Europa
- Cina
- India
- Corea del Sud< /li>
- Giappone
- Australia
- Resto dell'APAC
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- Brasile
- Argentina
- Resto dello SCAM
Profili aziendali
- IDEXX Laboratories, Inc.
- Zoetis, Inc.
- Virbac
- Heska Corporation
- Biopanda Reagents, Ltd.
- Fassisi GmbH
- BioNote, Inc. < li>SWISSAVANS AG
- MEGACOR Diagnostik GmbH
- Woodley Equipment Company
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Driving factors include the increasing incidences of zoonotic diseases and increasing initiatives by the governments and animal welfare associations of different countries. The increasing demand for rapid tests and portable instruments, and the use of advanced technologies such as machine learning is offering potential growth opportunities for the veterinary rapid test market.
Various companies have made organic growth strategies in the veterinary rapid test market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
IDEXX Laboratories, Inc, and Zoetis, Inc. are the top players of the market.
The market players are adopting the strategies such as new product launch, regional expansion, and technological advancements to increase their market share. Rising demand for rapid tests, point of care testing, and portable instruments are encouraging the new product launches in veterinary rapid testing.
The rapid test readers segment is growing at the highest CAGR owing to increasing demand for rapid test.
The Asia Pacific region is expected to account for the fastest growth in the veterinary rapid test market. Increase in government investments and increasing number of diagnostic centers in this region contribute to this dominant share. Additionally, wide range of effective measures adopted by government animal welfare organizations are said to be responsible for this growth.
The List of Companies - Veterinary Rapid Test Market
- IDEXX Laboratories, Inc.
- Zoetis, Inc.
- Virbac
- Heska Corporation,
- Biopanda Reagents, Ltd.
- Fassisi GmbH
- BioNote, Inc.
- SWISSAVANS AG
- MEGACOR Diagnostik GmbH
- Woodley Equipment Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)